Northwest Biotherapeutics (NWBO) Invested Capital (2016 - 2025)
Historic Invested Capital for Northwest Biotherapeutics (NWBO) over the last 17 years, with Q3 2025 value amounting to -$99.0 million.
- Northwest Biotherapeutics' Invested Capital fell 3956.21% to -$99.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$99.0 million, marking a year-over-year decrease of 3956.21%. This contributed to the annual value of -$84.9 million for FY2024, which is 5005.57% down from last year.
- As of Q3 2025, Northwest Biotherapeutics' Invested Capital stood at -$99.0 million, which was down 3956.21% from -$91.3 million recorded in Q2 2025.
- Northwest Biotherapeutics' 5-year Invested Capital high stood at -$11.3 million for Q1 2021, and its period low was -$1.3 billion during Q3 2023.
- In the last 5 years, Northwest Biotherapeutics' Invested Capital had a median value of -$52.3 million in 2023 and averaged -$118.8 million.
- In the last 5 years, Northwest Biotherapeutics' Invested Capital crashed by 369790.34% in 2023 and then surged by 9469.47% in 2024.
- Quarter analysis of 5 years shows Northwest Biotherapeutics' Invested Capital stood at -$17.2 million in 2021, then tumbled by 176.31% to -$47.5 million in 2022, then dropped by 19.02% to -$56.6 million in 2023, then tumbled by 50.06% to -$84.9 million in 2024, then fell by 16.58% to -$99.0 million in 2025.
- Its Invested Capital was -$99.0 million in Q3 2025, compared to -$91.3 million in Q2 2025 and -$90.0 million in Q1 2025.